`a`
Discrete and Continuous Dynamical Systems - Series B (DCDS-B)
 

Optimal control applied to a generalized Michaelis-Menten model of CML therapy
Pages: 331 - 346, Issue 1, January 2018

doi:10.3934/dcdsb.2018022      Abstract        References        Full text (451.6K)           Related Articles

Urszula Ledzewicz - Department of Mathematics and Statistics, Southern Illinois University at Edwardsville, Edwardsville, IL 62026-1653, United States (email)
Helen Moore - Bristol-Myers Squibb, Quantitative Clinical Pharmacology, Princeton, NJ 08543, United States (email)

1 E. K. Afenya and C. Calderón, Diverse ideas on the growth kinetics of disseminated cancer cells, Bull. Math. Biol., 62 (2000), 527-542.
2 P. Bonate, Pharmacokinetic and Pharmacodynamic Modeling and Simulation, 2nd Ed., Springer, New York, NY, 2011.
3 B. Bonnard and M. Chyba, Singular Trajectories and their Role in Control Theory, Springer, Series: Mathematics and Applications, Vol. 40, 2003.       
4 A. Bressan and B. Piccoli, Introduction to the Mathematical Theory of Control, American Institute of Mathematical Sciences, 2007.       
5 G. E. Briggs and J. B. Haldane, A note on the kinetics of enzyme action, Biochem. J., 19 (1925), 338-339.
6 B. Chereda and J. V. Melo, Natural course and biology of CML, Ann. Hematol., 94 (2015), 107-121.
7 H. Derendorf and B. Meibohm, Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives, Pharm. Res., 16 (1999), 176-185.
8 S. Faderl, M. Talpaz, Z. Estrov, S. O'Brien, R. Kurzrock and H. Kantarjian, The biology of chronic myeloid leukemia, New England J. of Medicine, 341 (1999), 164-172.
9 A. Källén, Computational Pharmacokinetics, Chapman and Hall, CRC, London, 2007.
10 U. Ledzewicz and H. Moore, Dynamical systems properties of a mathematical model for treatment of CML, Applied Sciences, 6 (2016), p291,
11 P. Macheras and A. Iliadin, Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics, Interdisciplinary Applied Mathematics, Vol. 30, 2nd ed., Springer, New York, 2016.       
12 L. Michaelis and M. L. Menten, Die kinetik der invertinwirkung, Biochem. Zeitschrift, 49 (1913), 333-369.
13 H. Moore, L. Strauss and U. Ledzewicz, Mathematical optimization of combination therapy for chronic myeloid leukemia (CML), A poster presented at the 6th American Conference on Pharmacometrics, Crystal City, VA, October 4-7, 2015.
14 A. Nakamura-Ishizu, H. Takizawa and T. Suda, The analysis, roles and regulation of quiescence in hematopoietic stem cells, Development, 141 (2014), 4656-4666.
15 L. S. Pontryagin, V. G. Boltyanskii, R. V. Gamkrelidze and E. F. Mishchenko, The Mathematical Theory of Optimal Processes, MacMillan, New York, 1964.       
16 M. Rowland and T. N. Tozer, Clinical Pharmacokinetics and Pharmacodynamics, Wolters Kluwer Lippicott, Philadelphia, 1995.
17 C. L. Sawyers, Chronic myeloid leukemia, New England J. of Medicine, 340 (1999), 1330-1340.
18 H. Schättler and U. Ledzewicz, Geometric Optimal Control: Theory, Methods and Examples, Springer Verlag, 2012.       
19 H. Schättler and U. Ledzewicz, Optimal Control for Mathematical Models of Cancer Therapies, Springer Verlag, 2015.       

Go to top